Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI-Rebound-Trial
2006-006731-45Phase 4Completed
- Sponsor
- Zealand University Hospital
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Esomeprazole (Nexium) with Placebo (2 arms). Started Mar 2007; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-006731-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006731-45.